Cargando…
Polymorphisms in the multidrug-resistance 1 gene related to glucocorticoid response in rheumatoid arthritis treatment
A substantial proportion of rheumatoid arthritis (RA)-patients experience an insufficient response to glucocorticoids, an important therapeutic agent in RA. The multidrug-resistance 1 (MDR1) gene product P-glycoprotein (P-gp) is an efflux pump that actively transports substrates, such as glucocortic...
Autores principales: | Cuppen, Bart V. J., Pardali, Katerina, Kraan, Maarten C., Marijnissen, Anne C. A., Yrlid, Linda, Olsson, Marita, Bijlsma, Johannes W. J., Lafeber, Floris P. J. G., Fritsch-Stork, Ruth D. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357283/ https://www.ncbi.nlm.nih.gov/pubmed/28132103 http://dx.doi.org/10.1007/s00296-017-3653-1 |
Ejemplares similares
-
Differences between serum polar lipid profiles of male and female rheumatoid arthritis patients in response to glucocorticoid treatment
por: Fu, Junzeng, et al.
Publicado: (2016) -
Can baseline serum microRNAs predict response to TNF-alpha inhibitors in rheumatoid arthritis?
por: Cuppen, Bart V. J., et al.
Publicado: (2016) -
Polymorphisms in the glucocorticoid receptor gene and in the glucocorticoid-induced transcript 1 gene are associated with disease activity and response to glucocorticoid bridging therapy in rheumatoid arthritis
por: Quax, R. A. M., et al.
Publicado: (2015) -
Tocilizumab as monotherapy or combination therapy for treating active rheumatoid arthritis: a meta-analysis of efficacy and safety reported in randomized controlled trials
por: Teitsma, Xavier M., et al.
Publicado: (2016) -
Exploring the Inflammatory Metabolomic Profile to Predict Response to TNF-α Inhibitors in Rheumatoid Arthritis
por: Cuppen, Bart V. J., et al.
Publicado: (2016)